about
A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical CorrelatesA Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.REM sleep and its Loss-Associated Epigenetic Regulation with Reference to Noradrenaline in ParticularLevomilnacipran for the treatment of major depressive disorder: a reviewNonaggressive and adapted social cognition is controlled by the interplay between noradrenergic and nicotinic receptor mechanisms in the prefrontal cortex.Behavioural screening of zebrafish using neuroactive traditional Chinese medicine prescriptions and biological targets.Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trialsModulation of induced frontocentral theta (Fm-θ) event-related (de-)synchronisation dynamics following mindfulness-based cognitive therapy in Major Depressive DisorderMolecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitusMajor depressive disorder: mechanism-based prescribing for personalized medicineLevomilnacipran Extended-Release Treatment in Patients With Major Depressive Disorder: Improvements in Functional Impairment Categories.Time-dependent behavioral, neurochemical, and metabolic dysregulation in female C57BL/6 mice caused by chronic high-fat diet intake.Biphasic Effects of α-Asarone on Immobility in the Tail Suspension Test: Evidence for the Involvement of the Noradrenergic and Serotonergic Systems in Its Antidepressant-Like ActivityCompartmental modeling of [(11)C]MENET binding to the norepinephrine transporter in the healthy human brainAssessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors.Blonanserin - A Novel Antianxiety and Antidepressant Drug? An Experimental Study.Prenatal SSRI exposure: Effects on later child development.An integrated modelling framework for neural circuits with multiple neuromodulators.New directions for the treatment of depression: Targeting the photic regulation of arousal and mood (PRAM) pathway.Defensive coping and essential amino acid markers as possible predictors for structural vascular disease in an African and Caucasian male cohort: The SABPA study.Vegetated land cover near residence is associated with reduced allostatic load and improved biomarkers of neuroendocrine, metabolic and immune functions.Uncertainty, epistemics and active inference.Antidepressant-Like Effect of Lipid Extract of Channa striatus in Postpartum Model of Depression in Rats.The association between alcohol abuse and neuroendocrine system dysregulation: Race differences in a National sample.Development and validation of a simple, rapid and sensitive LC-MS/MS method for the measurement of urinary neurotransmitters and their metabolites.Early Life Stress, Depression And Parkinson's Disease: A New Approach.Vagus Nerve as Modulator of the Brain-Gut Axis in Psychiatric and Inflammatory Disorders.Blood and urinary metabolomic evidence validating traditional Chinese medicine diagnostic classification of major depressive disorderDSM-5 Criteria and Depression Severity: Implications for Clinical PracticeMatured Hop-Derived Bitter Components in Beer Improve Hippocampus-Dependent Memory Through Activation of the Vagus NerveErbB4 deletion in noradrenergic neurons in the locus coeruleus induces mania-like behavior via elevated catecholaminesKetamine influences the locus coeruleus norepinephrine network, with a dependency on norepinephrine transporter genotype - a placebo controlled fMRI study
P2860
Q26786354-567A924C-A4A7-42FC-BE35-CADE50C7197FQ28068256-6A30389F-A541-4F78-B163-47D36FB7668CQ28073069-D7B3532B-2958-48B3-899A-981DD0374D07Q28083216-65850F07-9D1D-402B-B9AA-3ABF95E193E7Q30575556-21AEF648-E903-403B-8784-3042420E622DQ30580754-107E61B0-EAAD-42CF-A5EA-03C3D4302567Q33718213-CAFA50EE-0E0B-4C7F-85F1-66AF6A594815Q34135828-EB52854C-2BFF-446E-9D69-924AC9B44CD9Q34914164-7DCEA41E-A11C-40E9-A3F8-19A9FE1AD78BQ35284412-B85C351E-C846-4D2B-9259-F8B8BB67046BQ36083249-D27C26DF-4765-4DC3-8CA7-6E016D023070Q36665054-56FFC0A7-D1A9-4C9D-BF8F-983CA730B321Q36740078-8E8A5498-9241-41FD-9A09-B75C2B0F278FQ36880689-5694DB5A-0B9D-43A5-841B-C8D1A54284CDQ37308842-4E1F0525-082F-406C-8F72-9E71F87B151EQ37352996-766371A4-5074-4F6C-BBB7-336B04674A68Q38236646-0A7CFFEB-1B55-4DDC-A622-7D898B133326Q39013683-E0A70004-BFF3-403C-AF9B-FE473D2EF270Q39295637-9F157F75-B461-4A04-BA2F-A5D4C02C9331Q40327183-E8669B5C-72D9-4F14-AD6F-D18871303EFAQ40486461-F61DE125-AB55-4B37-8400-D069BD7EC5F3Q47142902-10CE3016-EA74-45F7-A425-8E838F52CEE6Q47556012-01687DBC-FD4D-40C7-8D32-BD816FED2091Q47703949-AB179BAE-1DDC-4C41-B761-FA2A6814E96AQ50067316-BB9AFFF9-F453-4EAD-A1E5-66C1E3BB094FQ52650242-47445E1E-16EA-4A31-BA33-99A7A762D7DCQ55233736-6215D6C0-F92C-47B8-B628-43D18E9C72BBQ58554187-B9C46CC1-74F7-42EF-A25A-90848F122DBCQ58587048-8D06B820-4168-4450-BA48-DB8E80980E36Q58603452-6FFBEA5C-5574-4339-A518-5849E77588BBQ58764052-3A38041C-2D28-4EDE-A659-004F5123D173Q58764387-971A1AFA-50E4-4874-A8C2-2A4EEF5E6548
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The importance of norepinephrine in depression.
@ast
The importance of norepinephrine in depression.
@en
type
label
The importance of norepinephrine in depression.
@ast
The importance of norepinephrine in depression.
@en
prefLabel
The importance of norepinephrine in depression.
@ast
The importance of norepinephrine in depression.
@en
P2860
P356
P1476
The importance of norepinephrine in depression.
@en
P2093
Chantal Moret
Mike Briley
P2860
P356
10.2147/NDT.S19619
P407
P433
P577
2011-05-31T00:00:00Z